Cytokines in myocarditis and dilated cardiomyopathy

European Heart Journal, Supplement

Volumn 4, Issue I, 2002, Pages

  Matsumori, A ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathy; Cytokines; Gene therapy; Myocarditis; NF kappa B

Indexed keywords

6 (3 DIMETHYLAMINOPROPIONYL)FORSKOLIN; 8 BROMO CYCLIC AMP; AMRINONE; CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; PHOSPHODIESTERASE INHIBITOR; PIMOBENDAN; PIPERANOMETOZINE; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL MODEL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ELECTROPORATION; ENCEPHALOMYOCARDITIS VIRUS; GENE THERAPY; HEART DILATATION; HEART FAILURE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; MYOCARDITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SURVIVAL;

EID: 0036899216     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90109-4     Document Type: Conference Paper

References (11)

1. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72: 561-6.
2. Shioi T, Matsumori A, Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 1996; 94: 2930-7.
3. Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994; 89: 846-51.
4. Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999; 100: 1102-8.
5. Shioi T, Matsumori A, Nishio R, Ono K, Kakio T, Sasayama S. Protective role of interleukin-12 in viral myocarditis. J Mol Cell Cardiol 1997; 29: 2327-34.
6. Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S. Differential modulation of cytokine production by drugs: Implications for therapy in heart failure. J Mol Cell Cardiol 1996; 28: 2491-9.
7. Matsumori A, Okada I, Shioi T, et al. Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Life Sci 1996; 59: L121-5.
8. Iwasaki A, Matsumori A, Yamada T, et al. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. J Am Coll Cardiol 1999; 33: 1400-7.
9. Matsumori A, Nunokawa Y, Sasayama S. Pimobendan inhibits the activation of transcription factor NF-κB. A mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase. Life Sci 2000; 67: 2513-9.
10. Nakano A, Matsumori A, Kawamoto S, et al. Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther 2001; 12: 1289-97.
11. Adachi O, Nakano A, Sato O, et al. Gene transfer of Fc-fusion cytokine by in vivo electroporation: Application to gene therapy for viral myocarditis. Gene Ther 2002; 9: 577-83.